IMPACT OF RENAL IMPAIRMENT ON PLATELET REACTIVITY AND CLINICAL OUTCOMES DURING CHRONIC DUAL ANTIPLATELET THERAPY FOLLOWING CORONARY STENTING

被引：0
|
作者：
Kim, M. H. [1 ]
Guo, L. Z. [2 ]
Shim, C. H. [2 ]
Choi, S. Y. [2 ]
Serebruany, V. L. [3 ]
机构：
[1] Dong A Univ Hosp, Global Clin Trial Ctr, Cardiol, Busan, South Korea
[2] Dong A Univ Hosp, Busan, South Korea
[3] Johns Hopkins Univ, HeartDrug Res Labs, Baltimore, MD USA
来源：
THROMBOSIS RESEARCH | 2016年 / 141卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C0152
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [21] Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome
    Tatarunas, Vacis
    Kupstyte-Kristapone, Nora
    Zvikas, Vaidotas
    Jakstas, Valdas
    Zaliunas, Remigijus
    Lesauskaite, Vaiva
    SCIENTIFIC REPORTS, 2020, 10 (01) : 3175
  • [22] Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome
    Vacis Tatarunas
    Nora Kupstyte-Kristapone
    Vaidotas Zvikas
    Valdas Jakstas
    Remigijus Zaliunas
    Vaiva Lesauskaite
    Scientific Reports, 10
  • [23] Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease
    Kao, Chih-Chin
    Wu, Mai-Szu
    Chuang, Ming-Tsang
    Lin, Yi-Cheng
    Huang, Chun-Yao
    Chang, Wei-Chiao
    Chen, Chih-Wei
    Chang, Tzu-Hao
    PLOS ONE, 2021, 16 (08):
  • [24] Triple versus dual antiplatelet therapy after coronary stenting: Impact on the stent thrombosis
    Lee, SW
    Park, SW
    Hong, MK
    Lee, CW
    Kim, YH
    Lee, NH
    Cho, YH
    Kim, JJ
    Park, SJ
    CIRCULATION, 2004, 110 (17) : 383 - 383
  • [25] Prognostic implications of high platelet reactivity in patients with diabetes mellitus and coronary artery disease on chronic dual antiplatelet therapy
    Angiolillo, D. J.
    Bernardo, E.
    Sabate, M.
    Jimenez-Quevedo, P.
    Palazuelos, J.
    Hernandez-Antolin, R.
    Costa, M. A.
    Bass, T. A.
    Macaya, C.
    Fernandez-Ortiz, A.
    EUROPEAN HEART JOURNAL, 2007, 28 : 187 - 187
  • [26] Triple versus dual antiplatelet therapy after coronary stenting - Impact on stent thrombosis
    Lee, SW
    Park, SW
    Hong, MK
    Kim, YH
    Lee, BK
    Song, JM
    Han, KH
    Lee, CW
    Kang, DH
    Song, JK
    Kim, JJ
    Park, SJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) : 1833 - 1837
  • [27] Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy
    Hokimoto, Seiji
    Akasaka, Tomonori
    Tabata, Noriaki
    Arima, Yuichiro
    Tsujita, Kenichi
    Sakamoto, Kenji
    Kaikita, Koichi
    Morita, Kazunori
    Kumagae, Naoki
    Yamamoto, Eiichiro
    Oniki, Kentaro
    Nakagawa, Kazuko
    Ogawa, Hisao
    THROMBOSIS RESEARCH, 2015, 135 (06) : 1081 - 1086
  • [28] Impact of Esomeprazole on Platelet Reactivity and Clinical Outcome According to CYP2C19 Genotype in Coronary Heart Disease Patients during Dual Antiplatelet Therapy
    Hokimoto, Seiji
    Kaikita, Koichi
    Nakaawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2014, 130
  • [29] DUAL ANTIPLATELET THERAPY BEYOND ONE YEAR FOLLOWING CORONARY STENTING IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION: A DUAL ANTIPLATELET THERAPY STUDY ANALYSIS
    Mauri, Laura
    Kereiakes, Dean
    Cutlip, Donald
    Yeh, Robert
    Steg, Philippe
    Wiviott, Stephen
    Massaro, Joseph
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 201 - 201
  • [30] 24- and 6-month dual antiplatelet therapy after coronary stenting did not differ for clinical outcomes
    Brott, Brigitta C.
    Hillegass, William B.
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (04)
12345